Rothschild SI, Zippelius A, Eboulet EI, Savic Prince S, et al. SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial. J Clin Oncol 2021 Jul 12:JCO2100276. doi: 10.1200/JCO.21.00276.
PMID: 34251873